Cheruvu Pavan 4
4 · Axovant Sciences Ltd. · Filed Feb 15, 2018
Insider Transaction Report
Form 4
Cheruvu Pavan
Chief Executive Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-02-13+1,940,185→ 1,940,185 totalExercise: $1.81Exp: 2028-02-12→ Common Shares (1,940,185 underlying)
Footnotes (1)
- [F1]25% of the common shares underlying the option will vest on February 11, 2019; the remainder vest in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying such option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.